Compare VFF & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | DCTH |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.1M | 372.5M |
| IPO Year | 2013 | 2015 |
| Metric | VFF | DCTH |
|---|---|---|
| Price | $2.12 | $11.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | ★ 995.0K | 496.8K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 184.38 | 107.53 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $215,937,000.00 | N/A |
| Revenue This Year | $12.19 | $24.54 |
| Revenue Next Year | $15.82 | $33.15 |
| P/E Ratio | $108.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $8.12 |
| 52 Week High | $4.99 | $16.44 |
| Indicator | VFF | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 31.13 | 62.00 |
| Support Level | N/A | $10.55 |
| Resistance Level | $3.66 | $11.98 |
| Average True Range (ATR) | 0.11 | 0.54 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 11.21 | 97.48 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.